People on the Move Archives - Page 119 of 137

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

August 12, 2025

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

August 11, 2025

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

August 7, 2025

THIS WEEK'S STORIES

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

August 12, 2025

Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors

August 13, 2025

BostonGene Wins “AI-based Drug Discovery Solution of the Year” at 2025 AI Breakthrough Awards

August 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Archimedic Names Aaron Pavkov Chief Innovation Officer to Drive Medical Device Development

CGT Global Appoints Dr. Jerome Ritz to Board of Advisors, Strengthening Expertise in Cell and Gene Therapies

KnoWEwell Names Functional Medicine Leader Dr. Patrick Hanaway as Chief Medical Officer

Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors

Ametros Strengthens Leadership Team with Two Key Hires to Enhance Member Services

Most Read

VitaTek Adds In-House Balloon Development Manufacturing to Streamline Medical Device Production

Apreo Health Treats First Patient in Pivotal BREATHE-3 Trial for Severe Emphysema

Archimedic Names Aaron Pavkov Chief Innovation Officer to Drive Medical Device Development

Sarepta Therapeutics Advances siRNA Program for DM1, Sells Arrowhead Stake to Fund $100M Milestone Payment

EDITOR PICKS

PureTech Launches Celea Therapeutics to Advance Treatment of Serious Respiratory Diseases

First Patient Dosed in Phase 3 Trial of Potential Dravet Syndrome Treatment

Boston IVF Adds Dr. Mary Morris to Massachusetts Fertility Team, Expanding Expertise in Oncofertility and Family Building

THIS WEEK'S STORIES

Merck’s KEYTRUDA-Padcev Combo Improves Survival for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients in Phase 3 Trial

Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors

BostonGene Wins “AI-based Drug Discovery Solution of the Year” at 2025 AI Breakthrough Awards

POPULAR CATEGORY

ABOUT US

FOLLOW US